Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Response to Woo and Eizirik

  1. David M. Nathan, MD and
  2. for the ADA/EASD Consensus Committee
  1. From the Diabetes Center, Massachusetts General Hospital, Boston, Massachusetts
  1. Corresponding author: David M. Nathan, dnathan{at}

We appreciate Dr. Woo's response to our study (1) and his comparison (2) of the Canadian Diabetes Association (CDA) clinical practice guidelines and the American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) consensus algorithm and welcome the opportunity to address the differences he has identified.

The original ADA/EASD consensus algorithm and the subsequent revisions were developed independently by the consensus group and were then presented to the two major diabetes organizations for their review and approval of the process. Dr. Woo notes the CDA's process of data review with a “standardized evidence-based approach” and the participation of “over 90 authors and a steering committee of 18” and concludes that the process removed “as much bias as possible,” implying that this approach was superior to our consensus algorithm process. He further notes …

| Table of Contents